insights_auto
Why is EDIT up 3,01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,88 US$
arrow_upward
+3,01%(+0,055) 1D
18 ნოე, 09:39:55 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 US$
High
1,92 US$
Low
1,84 US$
Mkt. cap
289,37 მლნ.
Avg. vol.
2,39 მლნ.
Volume
4,20 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,86 US$
High
1,92 US$
Low
1,84 US$
Mkt. cap
289,37 მლნ.
Avg. vol.
2,39 მლნ.
Volume
4,20 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Premarket Movers on Nov. 18
TradingView
·
52 წუთის წინ
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
Yahoo Finance
·
27 წუთის წინ
Investors Love the S&P 500 Index. Here’s Why I Don’t.
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc